China · Delayed Price · Currency is CNY Hubei Goto Biopharm Group Statistics
Total Valuation
SHE:300966 has a market cap or net worth of CNY 2.75 billion. The enterprise value is 4.07 billion.
| Market Cap | 2.75B |
| Enterprise Value | 4.07B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jul 16, 2026 |
Share Statistics
SHE:300966 has 114.21 million shares outstanding. The number of shares has increased by 8.19% in one year.
| Current Share Class | 114.21M |
| Shares Outstanding | 114.21M |
| Shares Change (YoY) | +8.19% |
| Shares Change (QoQ) | +12.43% |
| Owned by Insiders (%) | 43.13% |
| Owned by Institutions (%) | 5.04% |
| Float | 56.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.23 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 3.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 39.68 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.27 |
| EV / EBITDA | 58.62 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.45 |
| Debt / EBITDA | 18.96 |
| Debt / FCF | -78.20 |
| Interest Coverage | -2.58 |
Financial Efficiency
Return on equity (ROE) is -11.05% and return on invested capital (ROIC) is -2.91%.
| Return on Equity (ROE) | -11.05% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -2.91% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | 727,941 |
| Profits Per Employee | -106,437 |
| Employee Count | 893 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -14.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.21% in the last 52 weeks. The beta is 0.60, so SHE:300966's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +9.21% |
| 50-Day Moving Average | 26.18 |
| 200-Day Moving Average | 23.44 |
| Relative Strength Index (RSI) | 41.61 |
| Average Volume (20 Days) | 2,917,953 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300966 had revenue of CNY 650.05 million and -95.05 million in losses. Loss per share was -0.82.
| Revenue | 650.05M |
| Gross Profit | 58.65M |
| Operating Income | -62.59M |
| Pretax Income | -120.26M |
| Net Income | -95.05M |
| EBITDA | 69.44M |
| EBIT | -62.59M |
| Loss Per Share | -0.82 |
Balance Sheet
The company has 75.48 million in cash and 1.32 billion in debt, with a net cash position of -1.24 billion or -10.88 per share.
| Cash & Cash Equivalents | 75.48M |
| Total Debt | 1.32B |
| Net Cash | -1.24B |
| Net Cash Per Share | -10.88 |
| Equity (Book Value) | 910.61M |
| Book Value Per Share | 7.78 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 69.31 million and capital expenditures -86.16 million, giving a free cash flow of -16.85 million.
| Operating Cash Flow | 69.31M |
| Capital Expenditures | -86.16M |
| Depreciation & Amortization | 132.03M |
| Net Borrowing | 34.69M |
| Free Cash Flow | -16.85M |
| FCF Per Share | -0.15 |
Margins
Gross margin is 9.02%, with operating and profit margins of -9.63% and -14.62%.
| Gross Margin | 9.02% |
| Operating Margin | -9.63% |
| Pretax Margin | -18.50% |
| Profit Margin | -14.62% |
| EBITDA Margin | 10.68% |
| EBIT Margin | -9.63% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.19% |
| Shareholder Yield | -8.02% |
| Earnings Yield | -3.46% |
| FCF Yield | -0.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |